Vimarsana
Biggest News Aggregation in the World

Page 6 - Nasdaq Cccc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Cccc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cccc Today - Breaking & Trending Today

Brokerages Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Target Price at $11.86 - Vimarsana News

Brokerages Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Target Price at $11.86

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) has been given a consensus recommendation of “Hold” by the seven analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The […]

Source: wkrb13.com
Analyzing C4 Therapeutics (NASDAQ:CCCC) and Voyager Therapeutics (NASDAQ:VYGR) - Vimarsana News

Analyzing C4 Therapeutics (NASDAQ:CCCC) and Voyager Therapeutics (NASDAQ:VYGR)

C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Earnings & Valuation This table compares C4 Therapeutics and […]

C4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Update - Vimarsana News

C4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Update

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 2,830,000 shares, an increase of 7.6% from the March 31st total of 2,630,000 shares. Based on an average trading volume of 572,100 shares, the days-to-cover ratio is currently 4.9 days. […]

Source: wkrb13.com
C4 Therapeutics (NASDAQ:CCCC) vs. Innate Pharma (OTCMKTS:IPHYF) Financial Survey - Vimarsana News

C4 Therapeutics (NASDAQ:CCCC) vs. Innate Pharma (OTCMKTS:IPHYF) Financial Survey

C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Innate Pharma (OTCMKTS:IPHYF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings and analyst recommendations. Risk and Volatility C4 Therapeutics has a beta of […]

C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Rating of "Hold" by Brokerages - Vimarsana News

C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Rating of "Hold" by Brokerages

Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating […]